UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2004-02, Vol.22 (3), p.454-463

2004

Volltextzugriff (PDF)

Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

Journal of clinical oncology, 2002-01, Vol.20 (1), p.289-296

Motzer, R. J.

2002

Volltextzugriff (PDF)

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

Journal of clinical oncology, 2002, Vol.20 (1), p.289-296

2002

Volltextzugriff (PDF)

Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

Journal of clinical oncology, 2005-09, Vol.23 (27), p.6549-6555

2005

Volltextzugriff (PDF)

Phase III Randomized Trial of Conventional-Dose Chemotherapy With or Without High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Rescue As First-Line Treatment for Patients With Poor-Prognosis Metastatic Germ Cell Tumors

Journal of clinical oncology, 2007-01, Vol.25 (3), p.247-256

2007

Volltextzugriff (PDF)

Treatment Outcome and Survival Associated With Metastatic Renal Cell Carcinoma of Non–Clear-Cell Histology

Journal of clinical oncology, 2002-05, Vol.20 (9), p.2376-2381

2002

Volltextzugriff (PDF)

Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2530-2540

1999

Volltextzugriff (PDF)

Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group

Clinical cancer research, 2011-08, Vol.17 (16), p.5443-5450

2011

Volltextzugriff (PDF)

The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer

Diseases of the colon & rectum, 2005-07, Vol.48 (7), p.1353-1365

2005

Volltextzugriff (PDF)

Phase II Trial of Bortezomib for Patients With Advanced Renal Cell Carcinoma

Journal of clinical oncology, 2004-09, Vol.22 (18), p.3720-3725

2004

Volltextzugriff (PDF)

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

Journal of clinical oncology, 2007-01, Vol.25 (1), p.85-90

2007

Volltextzugriff (PDF)

Methods for categorizing a prognostic variable in a multivariable setting

Statistics in medicine, 2003-02, Vol.22 (4), p.559-571

2003

Volltextzugriff (PDF)

Etoposide and Cisplatin Chemotherapy for Metastatic Good-Risk Germ Cell Tumors

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9290-9294

2005

Volltextzugriff (PDF)

Treatment outcome for metastatic papillary renal cell carcinoma patients

Cancer, 2006-12, Vol.107 (11), p.2617-2621

2006

Volltextzugriff (PDF)

Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell Carcinoma

Journal of clinical oncology, 2000-08, Vol.18 (16), p.2972-2980

2000

Volltextzugriff (PDF)

Paclitaxel, Ifosfamide, and Cisplatin Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Cancer

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2413-2418

2000

Volltextzugriff (PDF)

Incidence of Late-Relapse Germ Cell Tumor and Outcome to Salvage Chemotherapy

Journal of clinical oncology, 2005-10, Vol.23 (28), p.6999-7004

2005

Volltextzugriff (PDF)

Phase II Trial of Thalidomide for Patients With Advanced Renal Cell Carcinoma

Journal of clinical oncology, 2002-01, Vol.20 (1), p.302-306

Motzer, R. J.

2002

Volltextzugriff (PDF)

Effect of Cytokine Therapy on Survival for Patients With Advanced Renal Cell Carcinoma

Journal of clinical oncology, 2000-05, Vol.18 (9), p.1928-1935

2000

Volltextzugriff (PDF)

Relapse-Free and Overall Survival in Patients With Pathologic Stage II Nonseminomatous Germ Cell Cancer Treated With Etoposide and Cisplatin Adjuvant Chemotherapy

Journal of clinical oncology, 2004-02, Vol.22 (3), p.464-467

2004

Volltextzugriff (PDF)

Outcome of Postchemotherapy Surgery After Treatment With Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients With Unresectable or Metastatic Transitional Cell Carcinoma

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2546-2552

1999

Volltextzugriff (PDF)

Role of Postchemotherapy Adjunctive Surgery in the Management of Patients With Nonseminoma Arising From the Mediastinum

Journal of clinical oncology, 2001-02, Vol.19 (3), p.682-688

2001

Volltextzugriff (PDF)

Sunitinib in patients with metastatic renal cell carcinoma

JAMA : the journal of the American Medical Association, 2006-06, Vol.295 (21), p.2516

2006

Volltextzugriff (PDF)

Prognostic Factors for Survival of Patients with Stage IV Renal Cell Carcinoma

Clinical cancer research, 2004-09, Vol.10 (18), p.6302S-6303S

2004

Volltextzugriff (PDF)

Cluster Analysis of p53 and Ki67 Expression, Apoptosis, Alpha-Fetoprotein, and Human Chorionic Gonadotrophin Indicates a Favorable Prognostic Subgroup Within the Embryonal Carcinoma Germ Cell Tumor

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2679-2688

2003

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(37)
Humans
(36)
Male
(32)
Biological And Medical Sciences
(27)
Medical Sciences
(27)
Oncology
(27)
Middle Aged
(26)
Adult
(24)
Female
(21)
Aged
(18)
Tumors
(16)
Treatment Outcome
(14)
Prognosis
(13)
Survival Analysis
(12)
Carcinoma, Renal Cell - Drug Therapy
(11)
Retrospective Studies
(11)
Aged, 80 And Over
(10)
Antineoplastic Agents
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma

Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

Phase III Randomized Trial of Conventional-Dose Chemotherapy With or Without High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Rescue As First-Line Treatment for Patients With Poor-Prognosis Metastatic Germ Cell Tumors

Treatment Outcome and Survival Associated With Metastatic Renal Cell Carcinoma of Non–Clear-Cell Histology

Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group

The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer

Phase II Trial of Bortezomib for Patients With Advanced Renal Cell Carcinoma

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

Methods for categorizing a prognostic variable in a multivariable setting

Etoposide and Cisplatin Chemotherapy for Metastatic Good-Risk Germ Cell Tumors

Treatment outcome for metastatic papillary renal cell carcinoma patients

Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell Carcinoma

Paclitaxel, Ifosfamide, and Cisplatin Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Cancer

Incidence of Late-Relapse Germ Cell Tumor and Outcome to Salvage Chemotherapy

Phase II Trial of Thalidomide for Patients With Advanced Renal Cell Carcinoma

Effect of Cytokine Therapy on Survival for Patients With Advanced Renal Cell Carcinoma

Relapse-Free and Overall Survival in Patients With Pathologic Stage II Nonseminomatous Germ Cell Cancer Treated With Etoposide and Cisplatin Adjuvant Chemotherapy

Outcome of Postchemotherapy Surgery After Treatment With Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients With Unresectable or Metastatic Transitional Cell Carcinoma

Role of Postchemotherapy Adjunctive Surgery in the Management of Patients With Nonseminoma Arising From the Mediastinum

Sunitinib in patients with metastatic renal cell carcinoma

Prognostic Factors for Survival of Patients with Stage IV Renal Cell Carcinoma

Cluster Analysis of p53 and Ki67 Expression, Apoptosis, Alpha-Fetoprotein, and Human Chorionic Gonadotrophin Indicates a Favorable Prognostic Subgroup Within the Embryonal Carcinoma Germ Cell Tumor

Suchergebnisse filtern